0.00
—
Close of 4 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Omed
Its shares trade under the ticker VICA. It has been listed since 6 October 2008. In the fiscal year to 31 December 2021, it reported revenue of $3.3m and a net loss of $879,207. At that date it held total assets of $7.7m and shareholders' equity of $4.0m.
Rafina Innovations, Inc. engages in the sale of medical devices. The company is also engaged in the technology development and licensing of bioengineering innovations for the health, sports and wellness sectors. The company was formed to sell medical devices with an emphasis on portable medical devices designed for home treatments with the initial focus in the northern regions of China. The company intends to seek strategic relationships with medical device manufacturers both in China and North America with the aim to be their sales and distribution agent in Northern China and to assist Chinese medical device manufacturers on the development of the North American market. Its subsidiaries include HCi Viocare Technologies Limited, HCi Viocare Clinics UK Limited and HCi Viocare Clinics (Hellas) S.A.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 6 Oct 2008
- Website
- hciviocare.com ↗
Leadership
Pay as last reported
- Mr. Constantinos ZertalisChairman of the Board, since 2018
- Mr. Paraskevi PylarinouChief Financial Officer, Secretary, Director, since 2018
- Mr. Georgios ThrapsaniotisTreasurer, Director, since 2018
- Mr. Yannis LevantisDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Rafina Innovations Inc has several key strengths that contribute to its success in the market. Firstly, the company possesses a highly skilled and innovative workforce, enabling them to develop cutting-edge technologies and solutions. Secondly, Rafina Innovations Inc has established strong partnerships with industry leaders, which enhances their access to resources and networks. Lastly, the company has a diversified product portfolio, allowing them to cater to a wide range of customer needs.
Weaknesses
- Despite its strengths, Rafina Innovations Inc also faces certain weaknesses that can hinder its growth. One of these weaknesses is the company's limited market presence and brand recognition, particularly in comparison to its competitors. Additionally, the company relies heavily on a few key clients for a significant portion of its revenue, making it vulnerable to potential client loss. Furthermore, the company may struggle with scalability as it expands its operations due to resource constraints.
Opportunities
- Rafina Innovations Inc can capitalize on several opportunities to fuel its growth and market position. Firstly, there is a growing demand for the type of innovative technologies and solutions offered by the company in various industries. Secondly, the increasing emphasis on sustainability and environmental consciousness opens up avenues for Rafina Innovations Inc to develop eco-friendly products. Lastly, the company can explore strategic collaborations and partnerships to expand its market reach and access new customer segments.
Threats
- Rafina Innovations Inc operates in a dynamic market landscape that poses certain threats to its operations. One of the primary threats is intense competition from established players in the industry, which may limit the company's market share. Additionally, economic downturns and fluctuations in the global market can impact customer spending on innovative solutions, posing a risk to the company's revenue streams. Moreover, regulatory changes and compliance requirements can add complexity and costs to the company's operations.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.